<DOC>
	<DOCNO>NCT02385032</DOCNO>
	<brief_summary>The purpose study evaluate bioavailability two formulation ursodiol .</brief_summary>
	<brief_title>Comparative Bioavailability Study UDCA</brief_title>
	<detailed_description />
	<mesh_term>Ursodeoxycholic Acid</mesh_term>
	<criteria>BMI ≥ 19.0 ≤ 30.0 kg/m2 . No clinically significant finding 12lead electrocardiogram ( ECG ) Be inform nature study give write consent prior study procedure Known history presence clinically significant medical condition Participated clinical trial involve administration investigational medicinal product within 30 day prior drug administration , recently participate clinical investigation , opinion investigator , would jeopardize subject safety integrity study result</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>